CU Anschutz In The News

Dr. Ihuoma Eneli, the head of the section on nutrition at Children’s Hospital Colorado and professor of pediatrics at the University of Colorado School of Medicine, explained the problem she said she and other pediatricians were struggling with: “How do we reconcile the message when we tell a child that weight doesn’t define them, that it’s just a number,” and then, in the next breath, suggest that the child take a weight loss medication?

The trial, involving scientists in Colorado, the United Kingdom and Italy, infused stem cells taken from the brain of a fetus that had died in a miscarriage into 15 Italian patients who already had significant disabilities caused by multiple sclerosis. In the year after the infusions, the patients’ multiple sclerosis didn’t get worse, and they didn’t have severe side effects from the stem cells.

CU Anschutz Dr. Brian Strickland talks about how to avoid altitude sickness

Eight cases this year were found in patients younger than 18 years old. Two people in total have died.

The course is the brainchild of Dr. Jay Lemery, director of the Climate and Health Program at the University of Colorado School of Medicine.

To Wei Perng, an associate professor of epidemiology at Colorado School of Public Health who has studied the effects of toxins on liver function, it was unclear why researchers thought the length of participants’ telomeres influenced the connection between liver scarring and toxin exposure. “What may be more powerful,” she said, is to consider the combination of shorter telomere length and environmental exposures.

The factors that impact the interplay between the microbiome and the human immune system begin at birth, according to Kristi Kuhn, MD, PhD, head of the division of rheumatology at the University of Colorado School of Medicine.

Many statements about the treatment were misleading, said Michael J. DiStefano, PhD, assistant professor of clinical pharmacy at the University of Colorado Anschutz Medical Campus, Aurora and a study co-author.  “We found one case of a straight-up, false statement, saying that ketamine is FDA-approved to treat depression,” DiStefano said. He hopes to expand the research nationally.